QSV Equity Investors’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.07M Sell
53,571
-25,535
-32% -$499K 1.58% 20
2025
Q3
$1.44M Hold
79,106
1.48% 25
2025
Q2
$1.59M Sell
79,106
-22,987
-23% -$442K 1.66% 17
2025
Q1
$1.85M Sell
102,093
-33,346
-25% -$598K 1.92% 12
2024
Q4
$2.35M Hold
135,439
2.26% 5
2024
Q3
$2.62M Sell
135,439
-100
-0.1% -$1.84K 2.45% 2
2024
Q2
$2.22M Sell
135,539
-779
-0.6% -$12.1K 2.32% 3
2024
Q1
$2.08M Buy
136,318
+905
+0.7% +$14.2K 2% 5
2023
Q4
$2.17M Buy
+135,413
New +$1.89M 2.11% 3

Other funds holding INVA

QSV Equity Investors's INVA Position: Q4 2025 in Review

QSV Equity Investors reduced its Innoviva (INVA) stake by 32% in Q4 2025, selling an estimated $499K and leaving 53,571 shares worth $1.07M. The position accounts for 1.58% of the portfolio, ranked #20.

QSV Equity Investors first reported a position in INVA in Q4 2023 and has held it in 9 quarters since. The position peaked at $2.62M in Q3 2024. 280 funds tracked by Wall St. Rank hold INVA as of Q4 2025.

  • QSV Equity Investors held 53,571 shares of Innoviva worth $1.07M as of Q4 2025.
  • QSV Equity Investors sold 25,535 Innoviva shares in Q4 2025, an estimated $499K.
  • Innoviva made up 1.58% of QSV Equity Investors's portfolio in Q4 2025, its #20 holding.
  • QSV Equity Investors first reported a position in Innoviva in Q4 2023 and has held it in 9 quarters since.
  • QSV Equity Investors's Innoviva position peaked at $2.62M in Q3 2024.
  • 280 funds tracked by Wall St. Rank held Innoviva as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.